SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study

B-cell-depleting agents are among the most commonly used drugs to treat haemato-oncological and autoimmune diseases. They rapidly induce a state of peripheral B-cell aplasia with the potential to interfere with nascent vaccine responses, particularly to novel antigens. We have examined the relations...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Adrian M, Venkatachalam, Srinivasan, Shafeek, Salim, Paneesha, Shankara, Ford, Mark, Sheeran, Tom, Kelly, Melanie, Qureshi, Iman, Salhan, Beena, Karim, Farheen, De Silva, Neelakshi, Stones, Jacqueline, Lee, Sophie, Khawaja, Jahanzeb, Kaudlay, Praveen Kumar, Whitmill, Richard, Kakepoto, Ghulam Nabi, Parry, Helen M, Moss, Paul, Faustini, Sian E, Richter, Alex G, Drayson, Mark T, Basu, Supratik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Editors’ Choice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767851/
https://www.ncbi.nlm.nih.gov/pubmed/35020852
http://dx.doi.org/10.1093/cei/uxab018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767851/
https://www.ncbi.nlm.nih.gov/pubmed/35020852
http://dx.doi.org/10.1093/cei/uxab018

Ejemplares similares